Deep-learning Imaging Platform to Prevent Diabetic Retinopathy
Camereyes has developed a simple end-to-end solution for detecting and monitoring diabetic retinopathy. The company's InSight leverages optics and deep-learning algorithms to provide a low-cost, fully automated solution in areas where professional eye care specialists may be scarce. InSight requires no special setup or skills, making it suitable for remote locations. Patients do not require pupil dilation; instead, they simply slip on a headset, and with the press of a button, high-quality fundus images are automatically captured and sent for storage in the cloud. Camereyes uses a network of professional reading centers with accredited graders supported by machine-learning algorithms to analyze the images and generate detailed reports, which are sent back within minutes to the point of care.
| Name | Camereyes |
|---|---|
| Slug | camereyes |
| Type / kind | startup |
| Crunchbase ID | Camereyes |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgO2Nj4QKDA |
| Status | inactive |
|---|---|
| Status reason | Non Active, Jan 2020 ceased to operate |
| Last update | 2026-05-17 |
| HQ country code | IL |
|---|---|
| HQ region/district | Jerusalem District |
| HQ city | Jerusalem |
| HQ address | Givat Ram, Jerusalem, Israel |
| https://www.linkedin.com/company/13212616 |
| Total raised | $950K |
|---|---|
| Current stage | Seed |
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}